Shares of MorphoSys AG (NASDAQ:MOR – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the […]